Search results
The new rule states that variations in treatment should be based primarily on differing patient needs and preferences. Doctors and other clinicians stand to gain a great deal from this change in perspective.
- 2001
On February 2, 2024, the Department of Health and Human Services (HHS) published its Final Rule, Medications for the Treatment of Opioid Use Disorder, revising the federal regulations governing opioid treatment programs (OTPs). The new rule is effective April 2, 2024, and OTPs must fully comply with the new rule no later than October 2, 2024.
Aug 2, 2023 · The Proposed Rule then creates a “special rule” for relevant data for NQTLs related to network composition, which states that “material differences” between access to MH/SUD benefits and M/S benefits are violations, in operation, of MHPAEA.
Apr 27, 2021 · NPR's Audie Cornish speaks with Dr. Nora Volkow, the director of the National Institute on Drug Abuse, about new rules that will make it easier to prescribe buprenorphine for opioid addiction.
- Audie Cornish
Jan 31, 2024 · The new rule significantly enhances OTP practitioner’s use of clinical judgement and discretion within opioid treatment programs (OTPs) by shifting from specific rigid, rules-based decision-making to a more flexible, person-centered care approach.
This paper analyzes difference-in-differences designs with a continuous treatment. We show that treatment effect on the treated-type parameters can be identified under a generalized parallel
People also ask
What is the new rule based on differences in treatment?
What does the new rule mean for patients?
What does a new rule mean for clinical decision-making?
What is the new health care rule about?
What is the new rule?
Overview. Drug Treatment Court (DTC) is a judicially supervised treatment program that enables persons suffering from a substance use disorder to meaningfully address their substance use.
